The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
Open accessAbstract
Toll-like receptors (TLRs) are the basic signaling receptors of the innate immune system. They are activated by molecules associated with pathogens or injured host cells and tissue. TLR3 has been shown to respond to double stranded (ds) RNA, a replication intermediary for many viruses. Here we present evidence that heterologous RNA released from or associated with necrotic cells or generated by in vitro transcription also stimulates TLR3 and induces immune activation. To assess RNA-mediated TLR3 activation, human embryonic kidney 293 cells stably expressing TLR3 and containing a nuclear factor-kappaB-dependent luciferase reporter were generated. Exposing these cells to in vitro transcribed RNA resulted in a TLR3-dependent induction of luciferase activity and interleukin-8 secretion. Treatment with in vitro transcribed mRNA activated nuclear factor-kappaB via TLR3 through a process that was dose-dependent and involved tyrosine phosphorylation. Furthermore, in vitro transcribed natural or 2'-fluoro-substituted mRNA induced the expression of TLR3, interferon regulatory factor-1, tumor necrosis factor-alpha, and interleukin-1 receptor-associated kinase-M mRNA in human dendritic cells (DCs). DCs responded to mRNA treatment by expressing activation markers, and this maturation was inhibited by antagonistic TLR3-specific antibody. Endogenous RNA released from or associated with necrotic cells also stimulated DCs, leading to interferon-alpha secretion, which could be abolished by pretreatment of necrotic cells with RNase. These results demonstrate that RNA, likely through secondary structure, is a potent host-derived activator of TLR3. This finding has potential physiologic relevance because RNA escaping from damaged tissue or contained within endocytosed cells could serve as an endogenous ligand for TLR3 that induces or otherwise modulates immune responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“not only viral RNA, but also endogenous mRNA associated with apoptotic cells as well as in vitro transcribed (IVT) mRNA could bind and activate TLR3, TLR7 and TLR8 [4,5]”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [4]
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319
Flagged first, then by citations
2 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- Armant, 2002, Genome Biol.
- Barton, 2002, Curr. Top. Microbiol. Immunol., 270, 81
- Vabulas, 2002, Curr. Top. Microbiol. Immunol., 270, 169
- Grentzmann, 1998, RNA (N. Y.), 4, 479
- Williams, 2001, Science's STKE
- Kirschning, 2002, Curr. Top. Microbiol. Immunol., 270, 121
- Larsson, 2003, Curr. Top. Microbiol. Immunol., 276, 261
- Belz, 2002, Crit. Rev. Immunol., 22, 439
Cited by
Sorted by citations
Items 401–500 of 1,000
Aspergillus fumigatusconidia induce interferon-β signalling in respiratory epithelial cells
Beißwenger, C., Hess, C., & Bals, R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00096110 · Cited by 59
Roh, Y. S., Kim, J. W., Park, S., Shon, C., Kim, S., Eo, S. K., Kwon, J. K., Lim, C. W., & Kim, B. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.011 · Cited by 55
Expression of Toll-like receptors (TLRs) and TLR4 response to lipopolysaccharide in hen oviduct
Ozoe, A., Isobe, N., & Yoshimura, Y. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.325 · Cited by 55
Gao, Y., Fang, X., Tong, Y. A., Liu, Y., & Zhang, B. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.06.028 · Cited by 56
Patel, A. K., & Hackam, A. S. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.11.005 · Cited by 56
Pseudoviral immunity – a novel concept for lupus
Anders, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.004 · Cited by 54
Sanghavi, S., & Reinhart, T. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5314 · Cited by 55
Andries, O., Filette, M. D., Smedt, S. C. D., Demeester, J., Poucke, M. V., Peelman, L. J., & Sanders, N. N. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.033 · Cited by 54
Stokes, J. A., Corr, M., & Yaksh, T. L. (2013) · Pain · doi:10.1016/j.pain.2013.01.012 · Cited by 56
Toll-like receptor 3 signaling attenuates liver regeneration #
Zorde‐Khvalevsky, E., Abramovitch, R., Barash, H., Spivak-Pohis, I., Rivkin, L., Rachmilewitz, J., Galun, E., & Giladi, H. (2009) · Hepatology · doi:10.1002/hep.22973 · Cited by 54
Higher Expression of Toll-Like Receptors 2 and 4 in Blood Cells of Keratoconus Patiens
Sobrino, T., Regueiro, U., Malfeito, M., Prado, A. V., Pérez‐Mato, M., Campos, F., & Lema, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-13525-7 · Cited by 54
Fukushima, Y., Uchida, S., Imai, H., Nakatomi, H., Kataoka, K., Saito, N., & Itaka, K. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120681 · Cited by 55
Toll-like receptor 3 regulates Mx expression in rare minnow Gobiocypris rarus after viral infection
Su, J., Zhu, Z., Wang, Y., Zou, J., & Hu, W. (2008) · Immunogenetics · doi:10.1007/s00251-007-0264-0 · Cited by 54
Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia
Mkaddem, S. B., Bens, M., & Vandewalle, A. (2010) · Oncotarget · doi:10.18632/oncotarget.209 · Cited by 54
TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology
Chen, C.-Y., Liu, H., & Hsueh, Y. (2016) · EMBO Reports · doi:10.15252/embr.201642586 · Cited by 54
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer
Pries, R., Hogrefe, L., Xie, L., Frenzel, H., Brocks, C., Ditz, C., & Wollenberg, B. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.2.209 · Cited by 53
Toll-like receptor sensing of human herpesvirus infection
West, J. A., Gregory, S. M., & Damania, B. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00122 · Cited by 53
Endogenous Retroelements and the Host Innate Immune Sensors
Mu, X. N., Ahmad, S., & Hur, S. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.07.001 · Cited by 56
The viral innate immune antagonism and an alternative vaccine design for PRRS virus
Ke, H., & Yoo, D. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.03.014 · Cited by 52
Uchida, S., Yoshinaga, N., Yanagihara, K., Yuba, E., Kataoka, K., & Itaka, K. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.033 · Cited by 52
Walker, D. G., Tang, T. M., & Lue, L. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.07.016 · Cited by 51
Sakaniwa, K., Fujimura, A., Shibata, T., Shigematsu, H., Ekimoto, T., Yamamoto, M., Ikeguchi, M., Miyake, K., Ohto, U., & Shimizu, T. (2023) · Nature Communications · doi:10.1038/s41467-023-35844-2 · Cited by 51
Toll-Like Receptors in Spinal Cord Injury
Kigerl, K. A., & Popovich, P. G. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-00549-7_7 · Cited by 50
Functional Toll-like receptors in primary first-trimester trophoblasts
Tangerås, L. H., Stødle, G. S., Olsen, G. D., Leknes, A.-H., Gundersen, A. S., Skei, B., Vikdal, A. J., Ryan, L., Steinkjer, B., Myklebost, M. F., et al. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.04.004 · Cited by 51
Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia
de Oliveira, A. C. P., Yousif, N. M., Bhatia, H. S., Hermanek, J., Hüell, M., & Fiebich, B. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0473-7 · Cited by 51
Poly I:C induces collective migration of HaCaT keratinocytes via IL-8
Takada, K., Komine‐Aizawa, S., Hirohata, N., Trinh, Q. D., Nishina, A., Kimura, H., & Hayakawa, S. (2017) · BMC Immunology · doi:10.1186/s12865-017-0202-3 · Cited by 53
Niimi, K., Asano, K., Shiraishi, Y., Nakajima, T., Wakaki, M., Kagyo, J., Takihara, T., Suzuki, Y., Fukunaga, K., Shiomi, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.489 · Cited by 52
Lateral Clustering of TLR3:dsRNA Signaling Units Revealed by TLR3ecd:3Fabs Quaternary Structure
Luo, J., Obmolova, G., Malia, T., Wu, S., Duffy, K. E., Marion, J. D., Bell, J. K., Ge, P., Zhou, Z., Teplyakov, A., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.05.006 · Cited by 52
Messenger RNA‐based vaccines: progress, challenges, applications
Kramps, T., & Probst, J. (2013) · WIREs RNA · doi:10.1002/wrna.1189 · Cited by 50
Vandestadt, C., Vanwalleghem, G. C., Khabooshan, M. A., Douek, A. M., Castillo, H. A., Li, M., Schulze, K. E., Don, E. K., Stamatis, S.-A., Ratnadiwakara, M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.07.021 · Cited by 50
An Update on mRNA-Based Viral Vaccines
Jeeva, S., Kim, K., Shin, C. H., Wang, B., & Kang, S. (2021) · Vaccines · doi:10.3390/vaccines9090965 · Cited by 49
Modern therapeutic approaches to liver-related disorders
Gardin, A., Remih, K., Gonzales, E. M., Andersson, E. R., & Strnad, P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.015 · Cited by 51
New insights into the immune functions of podocytes: the role of complement
Bruno, V., Mühlig, A. K., Oh, J. S., & Licht, C. P. B. (2023) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-023-00157-3 · Cited by 52
Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA)
Mansoori, B., Mohammadi, A., Shirjang, S., & Baradaran, B. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1102738 · Cited by 50
Vaccines against influenza A viruses in poultry and swine: Status and future developments
Rahn, J., Hoffmann, D., Harder, T., & Beer, M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.052 · Cited by 51
Derbigny, W. A., Hong, S., Kerr, M. S., Temkit, M., & Johnson, R. M. (2006) · Infection and Immunity · doi:10.1128/iai.01525-06 · Cited by 48
Hayashi, K., Hooper, L. C., Chin, M. S., Nagineni, C. N., Detrick, B., & Hooks, J. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81772-0 · Cited by 50
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
Sokal, A., Bastard, P., Chappert, P., Spaeth, G. B., Fourati, S., Vandenberghe, A., Lagouge-Roussey, P., Meyts, I., Gervais, A., Bouvier‐Alias, M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220258 · Cited by 49
Particulate Air pollution mediated effects on insulin resistance in mice are independent of CCR2
Liu, C., Xu, X., Bai, Y., Zhong, J., Wang, A., Sun, L., Kong, L., Ying, Z., Sun, Q., & Rajagopalan, S. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0187-3 · Cited by 47
Giuliani, K. T. K., Grivei, A., Nag, P., Wang, X., Rist, M. J., Kildey, K., Law, B. M. P., Ng, M. S. Y., Wilkinson, R., Ungerer, J. P. J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05191-z · Cited by 47
More than a delivery system: the evolving role of lipid-based nanoparticles
Karmaker, S., Rosales, P. D., Tirumuruhan, B., Viravalli, A., & Boehnke, N. (2025) · Nanoscale · doi:10.1039/d4nr04508d · Cited by 56
Exogenous RNA surveillance by proton-sensing TRIM25
Kim, M., Pyo, Y., Hyun, S., Jeong, M., Choi, Y., & Kim, V. N. (2025) · Science · doi:10.1126/science.ads4539 · Cited by 49
Multi-level regulation of cellular recognition of viral dsRNA
Peisley, A., & Hur, S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1149-4 · Cited by 46
TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury
Ding, X., Jin, S., Tong, Y., Jiang, X., Chen, Z., Mei, S., Zhang, L., Billiar, T. R., & Li, Q. (2017) · Scientific Reports · doi:10.1038/srep34278 · Cited by 51
Álvarez, K., & Vásquez, G. M. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1365146 · Cited by 48
New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs
Mahjoubin‐Tehran, M., Rezaei, S., Jesmani, A., Birang, N., Morshedi, K., Khanbabaei, H., Khan, H. Z., Piranviseh, A., Nejati, M., Aschner, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111753 · Cited by 48
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Acevedo‐Whitehouse, K. A., & Bruno, R. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111015 · Cited by 56
Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation
Kim, J., Jozić, A., Bloom, E., Jones, B., Marra, M., Murthy, N. T. V., Eygeris, Y., & Sahay, G. (2024) · ACS Nano · doi:10.1021/acsnano.4c00768 · Cited by 52
van Leeuwen, M. A., Lindenbergh-Kortleve, D. J., Raatgeep, H. C., de Ruiter, L. F., de Krijger, R. R., Groeneweg, M., Escher, J. C., & Samsom, J. N. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.19 · Cited by 47
Guardo, A. C., Joe, P. T., Miralles, L., Bargalló, M. E., Mothe, B., Krasniqi, A., Heirman, C., García, F., Thielemans, K., Brander, C., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001276 · Cited by 46
mRNA Cancer Vaccines—Messages that Prevail
Grunwitz, C. R., & Kranz, L. M. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_509 · Cited by 47
Nordström, E. K. L., Forsell, M. N. E., Barnfield, C., Bonin, E., Hanke, T., Sundström, M., Karlsson, G. B., & Liljeström, P. (2005) · Journal of General Virology · doi:10.1099/vir.0.80481-0 · Cited by 46
Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis
Guillerey, C., Chow, M. T., Miles, K. M., Olver, S. D., Sceneay, J., Takeda, K., Möller, A., & Smyth, M. J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1027468 · Cited by 45
Kim, H., Yang, E., Lee, J., Kim, S. H., Shin, J., Park, J. Y., Choi, S. J., Kim, S., & Choi, I. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02799.x · Cited by 45
Bonnin, M., Farés, N., Testoni, B., Estornes, Y., Weber, K., Vanbervliet, B., Lefrançois, L., Garcia, A. I., Kfoury, A., Pez, F., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.031 · Cited by 45
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis
Nussbaum, G. (2006) · International Immunology · doi:10.1093/intimm/dxl074 · Cited by 45
Role of toll-like receptors in systemic sclerosis
Ciechomska, M., Cant, R., Finnigan, J., van Laar, J. M., & O’Reilly, S. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.10 · Cited by 44
mRNA delivery using non-viral PCL nanoparticles
Palamà, I. E., Cortese, B., D’Amone, S., & Gigli, G. (2014) · Biomaterials Science · doi:10.1039/c4bm00242c · Cited by 44
Pattern recognition receptors in chronic pain: Mechanisms and therapeutic implications
Kato, J., Agalave, N. M., & Svensson, C. I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.039 · Cited by 44
Sheedy, F. J., Μαρίνου, Ι., O’Neill, L. A. J., & Wilson, A. G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083337 · Cited by 44
Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
Hudson, J., & Farkas, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212098 · Cited by 46
Translational and Clinical Significance of DAMPs, PAMPs, and PRRs in Trauma-induced Inflammation
Rai, V., Mathews, G., & Agrawal, D. K. (2022) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170279 · Cited by 43
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
Karim, M. E., Haque, S. T., Al-Busaidi, H., Bakhtiar, A., Tha, K. K., Holl, M. M. B., & Chowdhury, E. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01418-x · Cited by 45
Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases
MARSH, B., & Stenzel‐Poore, M. P. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.09.009 · Cited by 43
Ceppi, M., Ruggli, N., Tâche, V., Gerber, H., McCullough, K. C., & Summerfield, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.685 · Cited by 43
Roles of Toll-like Receptor Signaling in Inflammatory Bone Resorption
Tominari, T., Matsumoto, C., Tanaka, Y., Shimizu, K., Takatoya, M., Sugasaki, M., Karouji, K., Kasuga, U., Miyaura, C., Miyata, S., et al. (2024) · Biology · doi:10.3390/biology13090692 · Cited by 42
Transcriptional control of metabolism by interferon regulatory factors
Ahmad, Z., Kahloan, W., & Rosen, E. D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00990-0 · Cited by 45
Requirement of type I interferon signaling for arthritis triggered by double‐stranded RNA
Magnusson, M., Zare, F., & Tarkowski, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21517 · Cited by 42
The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness
Ma, K. C., Schenck, E. J., Pabón, M. A., & Choi, A. M. K. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2460pp · Cited by 45
Recent Advances in Zika Virus Vaccines
Garg, H., Mehmetoglu-Gurbuz, T., & Joshi, A. (2018) · Viruses · doi:10.3390/v10110631 · Cited by 44
Physiopathology of natural auto-antibodies: The case for regulation
Zelenay, S., Moraes‐Fontes, M. F., Fesel, C., Demengeot, J., & Coutinho, A. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.011 · Cited by 42
Gregory, G. L., & Copple, I. M. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.12.016 · Cited by 43
Ohkuni, T., Kojima, T., Ogasawara, N., Masaki, T., Fuchimoto, J., Kamekura, R., Koizumi, J.-I., Ichimiya, S., Murata, M., Tanaka, S., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.023 · Cited by 43
Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets
Cole, J. E., Mitra, A. T., & Monaco, C. G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.149 · Cited by 40
Delivery of synthetic mRNAs for tissue regeneration
Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 42
Ishii, K. J., & Akira, S. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.003 · Cited by 41
Impact of Polymorphisms of TLR4/CD14 and TLR3 on Acute Rejection in Kidney Transplantation
Hwang, Y., Ro, H., Choi, I., Kim, H., Oh, K., Hwang, J., Park, M. H., Kim, S., Yang, J., & Ahn, C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b2f34a · Cited by 40
Xu, S., Koldovsky, U., Xu, M., Wang, D. Y., Fitzpatrick, E., Son, G., Koski, G. K., & Czerniecki, B. J. (2006) · Surgery · doi:10.1016/j.surg.2006.03.006 · Cited by 40
Toll-Like Receptor 3 Increases Allergic and Irritant Contact Dermatitis
Nakamura, N., Tamagawa‐Mineoka, R., Ueta, M., Kinoshita, S., & Katoh, N. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.402 · Cited by 41
Yang, Y., Nam, G., Kim, G. B., Kim, Y. K., & Kim, I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.007 · Cited by 40
Emerging gene therapies for cystic fibrosis
Miah, K. M., Hyde, S. C., & Gill, D. R. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1634547 · Cited by 39
Ward, J. R., Wilson, H. L., Francis, S., Crossman, D. C., & Sabroe, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03886.x · Cited by 40
Inflammatory Regulation by TLR3 in Acute Hepatitis
Xiao, X., Zhao, P., Rodríguez‐Pinto, D., Qi, D., Henegariu, O., Alexopoulou, L., Flavell, R. A., Wong, F. S., & Li, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901221 · Cited by 40
Zou, L., Feng, Y., Xu, G., Jian, W., & Chao, W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502106 · Cited by 39
Yousif, N. M., de Oliveira, A. C. P., Brioschi, S., Hüell, M., Biber, K. P. H., & Fiebich, B. L. (2017) · Glia · doi:10.1002/glia.23276 · Cited by 40
Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
Mishra, V., & Pathak, C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.142 · Cited by 40
Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
Allan, K. M., Farrow, N., Donnelley, M., Jaffé, A., & Waters, S. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639475 · Cited by 42
Love, R. J., & Jones, K. S. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34577 · Cited by 39
Glavan, T. M., Gašparović, A. Č., Vérillaud, B., Busson, P., & Pavelić, J. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22584 · Cited by 39
Zhao, Y., & Wang, H. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf263 · Cited by 40
Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics
Kuhn, A. N., Diken, M., Kreiter, S., Vallazza, B., Türeci, Ö., & Sahin, U. (2011) · RNA Biology · doi:10.4161/rna.8.1.13767 · Cited by 39
Green, T. L., Santos, M. F., Ejaeidi, A. A., Craft, B. S., Lewis, R. E., & Cruse, J. M. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.05.003 · Cited by 38
Dufour, F., Bertrand, L., Pearson, A., Grandvaux, N., & Langelier, Y. (2011) · Journal of Virology · doi:10.1128/jvi.00362-11 · Cited by 38
Qi, D., Xia, M., Yan, C., Zhao, Y., & Wu, R. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.07.014 · Cited by 38
Chen, C., Gao, R., Li, M., Wang, Q., Chen, H., Zhang, S., Mao, X., Behensky, A. A., Zhang, Z., Gan, L., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.024 · Cited by 38
The Role of Danger Associated Molecular Patterns in Human Fetal Membrane Weakening
Padron, J. G., Reis, C. A. S., & Kendal‐Wright, C. E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00602 · Cited by 43
Extracellular dsRNA: Its Function and Mechanism of Cellular Uptake
Nellimarla, S., & Mossman, K. L. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0002 · Cited by 36
Østvik, A. E., Granlund, A. V. B., Gustafsson, B. I., TORP, S. H., Espevik, T., Mollnes, T. E., Damås, J. K., & Sandvik, A. K. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000035 · Cited by 38
Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3
Majde, J. A., Kapás, L., Bohnet, S. G., De, A., & Krueger, J. M. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.10.011 · Cited by 35
TLR3 Ligand Polyinosinic:Polycytidylic Acid Induces IL-17A and IL-21 Synthesis in Human Th Cells
Holm, C. K., Petersen, C. C., Hvid, M., Petersen, L., Paludan, S. R., Deleuran, B. W., & Hokland, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804318 · Cited by 37
Metadata
- Authors
- Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D.
- Affiliations
- University of Pennsylvania (US)
- Eisai (United States) (US)
- Corresponding author
- Karikó, Katalin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 12542-12550
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986178107
- Cited by
- 1,062
- References
- 63
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 39 · 2023: 64 · 2022: 48 · 2021: 55 · 2020: 37 · 2019: 32 · 2018: 41 · 2017: 51 · 2016: 38 · 2015: 46 · 2014: 46 · 2013: 57 · 2012: 67
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl062060-05)
- National Heart, Lung, and Blood Institute (HL62060-04)
- National Institute of Allergy and Infectious Diseases (AI-50484, R01AI050484)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TLR3, mRNA, endogenous ligands, innate immunity, dendritic cell maturation, necrotic cells, double-stranded RNA, interferon-alpha, NF-κB, tyrosine phosphorylation, IRF1, TNF-α, RNA secondary structure
- MeSH terms
- Cell Line, Dendritic Cells, Dose-Response Relationship, Drug, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Humans, Ligands, Luciferases, Membrane Glycoproteins, Necrosis, Nucleic Acid Conformation, Plasmids, Protein Kinases, Receptors, Cell Surface, RNA, RNA, Double-Stranded, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Necrosis Factor-alpha, Tyrosine, Blotting, Northern, Signal Transduction, Up-Regulation, Interleukin-8, NF-kappa B, Staurosporine, Genistein, Toll-Like Receptors, Toll-Like Receptor 3, Interleukin-1 Receptor-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review